GoodRx has named Christopher McGinnis as its new Chief Financial Officer, marking another key leadership transition following the appointment of a new CEO. McGinnis officially assumed the role on Tuesday, as announced in a company press release.
McGinnis joins GoodRx from CitizensRx, a midsized pharmacy benefit manager, where he served as CEO for nearly four years. His previous leadership experience includes roles at Lumeris, a value-based care firm that provides Medicare Advantage plans, and Express Scripts, one of the largest PBMs in the country.
He succeeds former CFO Karsten Voermann, who had held the position since 2020 but resigned last month for personal reasons, as noted in a securities filing. During the transition, GoodRx’s Chief Accounting Officer, Romin Nabiey, served as interim CFO until a permanent successor was found.
The executive shakeup follows the company’s recent appointment of Wendy Barnes as CEO. Barnes, who officially took on the role on January 1, previously worked at Express Scripts. She succeeded Scott Wagner, who served as interim CEO after GoodRx’s co-founders, Trevor Bezdek and Doug Hirsch, stepped down as co-CEOs in April 2023. Bezdek and Hirsch remain on the company’s board of directors, and Wagner also joined the board last month.
Despite starting the year with a lower stock price, GoodRx reported strong financial performance in the third quarter of 2024, with revenue reaching $195.3 million—a year-over-year increase of more than 8%. The company also posted a net income of nearly $4 million, recovering from a $38.5 million loss in the previous year.
